Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults	Craniopharyngioma, Child, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, craniopharyngioma, neoplasm, primitive neuroectodermal tumor	Recruiting	Phase 2	2026-04-23		NCT05465174

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Day One Biopharmaceuticals, Inc.	7
Sabine Mueller, MD, PhD	7

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago	United States	144
Children's Cancer Centre, Monash Children's Hospital	Clayton	Australia	1
Children's Hospital of Philadelphia	Philadelphia	United States	2
Children's Minnesota	Minneapolis	United States	13
Dana-Farber/Boston Children's Harvard Medical School	Boston	United States	1
Duke University Medical Center	Durham	United States	505
John Hopkins University	Baltimore	United States	6
John Hunter Children's Hospital	New Lambton Heights	Australia	1
NYU Langone Health	New York	United States	403
Perth Children's Hospital	Nedlands	Australia	20
Rady Children's Hospital/University of California, San Diego	San Diego	United States	1
Riley Hospital for Children at Indiana University Health	Indianapolis	United States	17
Royal Children's Hospital, Childrens' Cancer Centre	Parkville	Australia	1
Royal Hobart Hospital	Hobart	Australia	44
St. Louis Children's Hospital Washington University	St Louis	United States	1
University of Alabama at Birmingham	Birmingham	United States	247
University of California, San Francisco	San Francisco	United States	294
University of Florida	Gainesville	United States	79
University of Michigan	Ann Arbor	United States	538
University of Utah	Salt Lake City	United States	137

Clinical trials